Urinary Volatile Organic Compounds for the Detection of Prostate Cancer

T. Khalid, R. Aggio, C. S. Probert, P. White, B. De Lacy Costello, Huda Al-Kateb, P. Jones, N. Ratcliffe, R. Persad

Research output: Contribution to journalArticle

39 Citations (Scopus)
6 Downloads (Pure)

Abstract

The aim of this work was to investigate volatile organic compounds (VOCs) emanating from urine samples to determine whether they can be used to classify samples into those from prostate cancer and non-cancer groups. Participants were men referred for a trans-rectal ultrasound-guided prostate biopsy because of an elevated prostate specific antigen (PSA) level or abnormal findings on digital rectal examination. Urine samples were collected from patients with prostate cancer (n = 59) and cancer-free controls (n = 43), on the day of their biopsy, prior to their procedure. VOCs from the headspace of basified urine samples were extracted using solid-phase micro-extraction and analysed by gas chromatography/mass spectrometry. Classifiers were developed using Random Forest (RF) and Linear Discriminant Analysis (LDA) classification techniques. PSA alone had an accuracy of 62–64% in these samples. A model based on 4 VOCs, 2,6-dimethyl-7-octen-2-ol, pentanal, 3-octanone, and 2-octanone, was marginally more accurate 63–65%. When combined, PSA level and these four VOCs had mean accuracies of 74% and 65%, using RF and LDA, respectively. With repeated double cross-validation, the mean accuracies fell to 71% and 65%, using RF and LDA, respectively. Results from VOC profiling of urine headspace are encouraging and suggest that there are other metabolomic avenues worth exploring which could help improve the stratification of men at risk of prostate cancer. This study also adds to our knowledge on the profile of compounds found in basified urine, from controls and cancer patients, which is useful information for future studies comparing the urine from patients with other disease states.
Original languageEnglish
Article numbere0143283
JournalPLoS ONE
Volume10
Issue number11
DOIs
Publication statusPublished - 24 Nov 2015

Fingerprint

Volatile Organic Compounds
volatile organic compounds
prostatic neoplasms
Prostatic Neoplasms
urine
prostate-specific antigen
Urine
Discriminant analysis
Prostate-Specific Antigen
Discriminant Analysis
discriminant analysis
Biopsy
headspace analysis
biopsy
sampling
Digital Rectal Examination
neoplasms
Metabolomics
Gas chromatography
Solid Phase Extraction

Bibliographical note

The full text is also available from: http://dx.doi.org/10.1371/journal.pone.0143283

Cite this

Khalid, T., Aggio, R., Probert, C. S., White, P., De Lacy Costello, B., Al-Kateb, H., ... Persad, R. (2015). Urinary Volatile Organic Compounds for the Detection of Prostate Cancer. PLoS ONE, 10(11), [e0143283]. https://doi.org/10.1371/journal.pone.0143283

Urinary Volatile Organic Compounds for the Detection of Prostate Cancer. / Khalid, T.; Aggio, R.; Probert, C. S.; White, P.; De Lacy Costello, B.; Al-Kateb, Huda; Jones, P.; Ratcliffe, N.; Persad, R.

In: PLoS ONE, Vol. 10, No. 11, e0143283, 24.11.2015.

Research output: Contribution to journalArticle

Khalid, T, Aggio, R, Probert, CS, White, P, De Lacy Costello, B, Al-Kateb, H, Jones, P, Ratcliffe, N & Persad, R 2015, 'Urinary Volatile Organic Compounds for the Detection of Prostate Cancer' PLoS ONE, vol. 10, no. 11, e0143283. https://doi.org/10.1371/journal.pone.0143283
Khalid T, Aggio R, Probert CS, White P, De Lacy Costello B, Al-Kateb H et al. Urinary Volatile Organic Compounds for the Detection of Prostate Cancer. PLoS ONE. 2015 Nov 24;10(11). e0143283. https://doi.org/10.1371/journal.pone.0143283
Khalid, T. ; Aggio, R. ; Probert, C. S. ; White, P. ; De Lacy Costello, B. ; Al-Kateb, Huda ; Jones, P. ; Ratcliffe, N. ; Persad, R. / Urinary Volatile Organic Compounds for the Detection of Prostate Cancer. In: PLoS ONE. 2015 ; Vol. 10, No. 11.
@article{fa0f8be6677d483f850381feea5fcf7d,
title = "Urinary Volatile Organic Compounds for the Detection of Prostate Cancer",
abstract = "The aim of this work was to investigate volatile organic compounds (VOCs) emanating from urine samples to determine whether they can be used to classify samples into those from prostate cancer and non-cancer groups. Participants were men referred for a trans-rectal ultrasound-guided prostate biopsy because of an elevated prostate specific antigen (PSA) level or abnormal findings on digital rectal examination. Urine samples were collected from patients with prostate cancer (n = 59) and cancer-free controls (n = 43), on the day of their biopsy, prior to their procedure. VOCs from the headspace of basified urine samples were extracted using solid-phase micro-extraction and analysed by gas chromatography/mass spectrometry. Classifiers were developed using Random Forest (RF) and Linear Discriminant Analysis (LDA) classification techniques. PSA alone had an accuracy of 62–64{\%} in these samples. A model based on 4 VOCs, 2,6-dimethyl-7-octen-2-ol, pentanal, 3-octanone, and 2-octanone, was marginally more accurate 63–65{\%}. When combined, PSA level and these four VOCs had mean accuracies of 74{\%} and 65{\%}, using RF and LDA, respectively. With repeated double cross-validation, the mean accuracies fell to 71{\%} and 65{\%}, using RF and LDA, respectively. Results from VOC profiling of urine headspace are encouraging and suggest that there are other metabolomic avenues worth exploring which could help improve the stratification of men at risk of prostate cancer. This study also adds to our knowledge on the profile of compounds found in basified urine, from controls and cancer patients, which is useful information for future studies comparing the urine from patients with other disease states.",
author = "T. Khalid and R. Aggio and Probert, {C. S.} and P. White and {De Lacy Costello}, B. and Huda Al-Kateb and P. Jones and N. Ratcliffe and R. Persad",
note = "The full text is also available from: http://dx.doi.org/10.1371/journal.pone.0143283",
year = "2015",
month = "11",
day = "24",
doi = "10.1371/journal.pone.0143283",
language = "English",
volume = "10",
journal = "PLoS ONE",
issn = "1932-6203",
publisher = "Public Library of Science",
number = "11",

}

TY - JOUR

T1 - Urinary Volatile Organic Compounds for the Detection of Prostate Cancer

AU - Khalid, T.

AU - Aggio, R.

AU - Probert, C. S.

AU - White, P.

AU - De Lacy Costello, B.

AU - Al-Kateb, Huda

AU - Jones, P.

AU - Ratcliffe, N.

AU - Persad, R.

N1 - The full text is also available from: http://dx.doi.org/10.1371/journal.pone.0143283

PY - 2015/11/24

Y1 - 2015/11/24

N2 - The aim of this work was to investigate volatile organic compounds (VOCs) emanating from urine samples to determine whether they can be used to classify samples into those from prostate cancer and non-cancer groups. Participants were men referred for a trans-rectal ultrasound-guided prostate biopsy because of an elevated prostate specific antigen (PSA) level or abnormal findings on digital rectal examination. Urine samples were collected from patients with prostate cancer (n = 59) and cancer-free controls (n = 43), on the day of their biopsy, prior to their procedure. VOCs from the headspace of basified urine samples were extracted using solid-phase micro-extraction and analysed by gas chromatography/mass spectrometry. Classifiers were developed using Random Forest (RF) and Linear Discriminant Analysis (LDA) classification techniques. PSA alone had an accuracy of 62–64% in these samples. A model based on 4 VOCs, 2,6-dimethyl-7-octen-2-ol, pentanal, 3-octanone, and 2-octanone, was marginally more accurate 63–65%. When combined, PSA level and these four VOCs had mean accuracies of 74% and 65%, using RF and LDA, respectively. With repeated double cross-validation, the mean accuracies fell to 71% and 65%, using RF and LDA, respectively. Results from VOC profiling of urine headspace are encouraging and suggest that there are other metabolomic avenues worth exploring which could help improve the stratification of men at risk of prostate cancer. This study also adds to our knowledge on the profile of compounds found in basified urine, from controls and cancer patients, which is useful information for future studies comparing the urine from patients with other disease states.

AB - The aim of this work was to investigate volatile organic compounds (VOCs) emanating from urine samples to determine whether they can be used to classify samples into those from prostate cancer and non-cancer groups. Participants were men referred for a trans-rectal ultrasound-guided prostate biopsy because of an elevated prostate specific antigen (PSA) level or abnormal findings on digital rectal examination. Urine samples were collected from patients with prostate cancer (n = 59) and cancer-free controls (n = 43), on the day of their biopsy, prior to their procedure. VOCs from the headspace of basified urine samples were extracted using solid-phase micro-extraction and analysed by gas chromatography/mass spectrometry. Classifiers were developed using Random Forest (RF) and Linear Discriminant Analysis (LDA) classification techniques. PSA alone had an accuracy of 62–64% in these samples. A model based on 4 VOCs, 2,6-dimethyl-7-octen-2-ol, pentanal, 3-octanone, and 2-octanone, was marginally more accurate 63–65%. When combined, PSA level and these four VOCs had mean accuracies of 74% and 65%, using RF and LDA, respectively. With repeated double cross-validation, the mean accuracies fell to 71% and 65%, using RF and LDA, respectively. Results from VOC profiling of urine headspace are encouraging and suggest that there are other metabolomic avenues worth exploring which could help improve the stratification of men at risk of prostate cancer. This study also adds to our knowledge on the profile of compounds found in basified urine, from controls and cancer patients, which is useful information for future studies comparing the urine from patients with other disease states.

U2 - 10.1371/journal.pone.0143283

DO - 10.1371/journal.pone.0143283

M3 - Article

VL - 10

JO - PLoS ONE

JF - PLoS ONE

SN - 1932-6203

IS - 11

M1 - e0143283

ER -